Cerity Partners LLC Increases Position in Humana Inc. (NYSE:HUM)

Cerity Partners LLC grew its stake in shares of Humana Inc. (NYSE:HUM - Free Report) by 26.0% in the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 39,331 shares of the insurance provider's stock after acquiring an additional 8,119 shares during the period. Cerity Partners LLC's holdings in Humana were worth $10,407,000 at the end of the most recent quarter.

Several other hedge funds have also recently bought and sold shares of the stock. Retirement Planning Co of New England Inc. raised its position in Humana by 4.7% during the fourth quarter. Retirement Planning Co of New England Inc. now owns 966 shares of the insurance provider's stock valued at $245,000 after purchasing an additional 43 shares in the last quarter. Achmea Investment Management B.V. raised its position in Humana by 0.5% during the first quarter. Achmea Investment Management B.V. now owns 10,379 shares of the insurance provider's stock valued at $2,746,000 after purchasing an additional 49 shares in the last quarter. Beech Hill Advisors Inc. raised its position in Humana by 6.1% during the first quarter. Beech Hill Advisors Inc. now owns 865 shares of the insurance provider's stock valued at $229,000 after purchasing an additional 50 shares in the last quarter. Deseret Mutual Benefit Administrators raised its position in Humana by 15.8% during the first quarter. Deseret Mutual Benefit Administrators now owns 462 shares of the insurance provider's stock valued at $122,000 after purchasing an additional 63 shares in the last quarter. Finally, Vise Technologies Inc. raised its position in Humana by 8.0% during the fourth quarter. Vise Technologies Inc. now owns 873 shares of the insurance provider's stock valued at $221,000 after purchasing an additional 65 shares in the last quarter. 92.38% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

A number of research firms have weighed in on HUM. Bank of America lowered their price target on Humana from $320.00 to $260.00 and set a "neutral" rating on the stock in a research report on Tuesday, June 17th. Truist Financial lowered their price target on shares of Humana from $280.00 to $260.00 and set a "hold" rating for the company in a research note on Wednesday. Wall Street Zen downgraded shares of Humana from a "buy" rating to a "hold" rating in a research note on Saturday. Raymond James Financial raised shares of Humana from a "market perform" rating to an "outperform" rating and set a $315.00 price target for the company in a research note on Thursday, May 1st. Finally, Barclays set a $268.00 price target on shares of Humana and gave the stock an "equal weight" rating in a research note on Thursday, June 12th. Seventeen investment analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company's stock. According to data from MarketBeat.com, Humana presently has an average rating of "Hold" and a consensus price target of $279.81.

Humana Trading Up 2.1%

Shares of NYSE HUM traded up $4.72 during midday trading on Wednesday, hitting $226.62. 1,097,038 shares of the company traded hands, compared to its average volume of 1,812,407. Humana Inc. has a 12-month low of $212.45 and a 12-month high of $406.46. The company has a debt-to-equity ratio of 0.71, a quick ratio of 1.91 and a current ratio of 1.91. The stock has a 50-day moving average price of $236.05 and a 200 day moving average price of $257.67. The firm has a market cap of $27.35 billion, a P/E ratio of 16.03, a P/E/G ratio of 1.52 and a beta of 0.44.

Humana (NYSE:HUM - Get Free Report) last posted its quarterly earnings data on Wednesday, April 30th. The insurance provider reported $11.58 EPS for the quarter, topping the consensus estimate of $10.07 by $1.51. The business had revenue of $32.11 billion for the quarter, compared to analyst estimates of $32 billion. Humana had a net margin of 1.42% and a return on equity of 14.47%. Humana's quarterly revenue was up 8.4% on a year-over-year basis. During the same quarter in the previous year, the firm posted $7.23 earnings per share. As a group, analysts expect that Humana Inc. will post 16.47 earnings per share for the current year.

Humana Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, July 25th. Investors of record on Friday, June 27th will be given a dividend of $0.885 per share. The ex-dividend date of this dividend is Friday, June 27th. This represents a $3.54 dividend on an annualized basis and a yield of 1.56%. Humana's dividend payout ratio (DPR) is 25.04%.

Humana Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.